Brooks Nader reveals she tried weight-loss drug Ozempic but had to give it up while on Dancing With The Stars
Brooks admitted that when she was taking Ozempic she 'lost a little bit of the motivation and the strength to work out.' ...
'King Kong' weight loss drug to be given to less than 10% of eligible people in first rollout
Mounjaro will be rolled out gradually as officials said a "difficult decision" had to be made in order to "protect other ...
NHS gets 12 years to roll out new weight-loss drug
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
Major blow to patients waiting for new NHS jab - only 10% will get it straight away
To help the NHS manage demand, the health organisation's spending watchdog said about 220,000 people could benefit from the ...
Eli Lilly’s Obesity Drug Set for Slow NHS Rollout in England
England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to ...
Britain drug-cost watchdog says it will recommend Lilly obesity drug
Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...
STAT4h
U.K. to restrict Eli Lilly’s obesity drug to patients with greatest need
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...
AOL4h
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
It comes as a trial by Mounjaro manufacturer Eli Lilly – known as Surmount-5 – found patients on tirzepatide recorded a ...
Plymouth Herald4h
NHS Mounjaro warning as 90 per cent of people will be disappointed
It comes as a trial by Mounjaro manufacturer Eli Lilly – known as Surmount-5 – found patients on tirzepatide recorded a ...
Shares in Eli Lilly rise as Zepbound weight-loss study shows solid success
Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug ...
Health.com9h
Can’t Afford Ozempic, Other GLP-1 Drugs? Here’s What to Do, According to Experts
More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...